{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:24:49Z","timestamp":1785543889943,"version":"3.56.0"},"reference-count":14,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2013,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>To meet the needs of a global community, an immunoassay for cryptococcal antigen (CrAg) must have high sensitivity for CrAg of all major serotypes. A new immunoassay for CrAg in lateral flow format was evaluated and found to have a high sensitivity for detection of serotypes A, B, C, and D.<\/jats:p>","DOI":"10.1128\/cvi.00732-12","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T03:43:36Z","timestamp":1359603816000},"page":"634-635","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":35,"title":["Serotype Sensitivity of a Lateral Flow Immunoassay for Cryptococcal Antigen"],"prefix":"10.1128","volume":"20","author":[{"given":"Marcellene A.","family":"Gates-Hollingsworth","sequence":"first","affiliation":[{"name":"University of Nevada School of Medicine, Reno, Nevada, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Kozel","sequence":"additional","affiliation":[{"name":"University of Nevada School of Medicine, Reno, Nevada, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328322ffac"},{"key":"e_1_3_2_3_2","unstructured":"Cryptococcal Guideline Working Group WHO. 2011. Rapid advice: diagnosis prevention and management of cryptococcal disease in HIV-infected adults adolescents and children. World Health Organization Geneva Switzerland. http:\/\/whqlibdoc.who.int\/publications\/2011\/9789241502979_eng.pdf."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/cid\/cir613","article-title":"Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis","volume":"53","author":"Jarvis JN","year":"2011","unstructured":"JarvisJNPercivalABaumanSPelfreyJMeintjesGWilliamsGNLongleyNHarrisonTSKozelTR. 2011. Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis. Clin. Infect. Dis. 53:1019\u20131023.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3181\/00379727-127-32812","article-title":"Serologic grouping of Cryptococcus neoformans","volume":"127","author":"Wilson DE","year":"1968","unstructured":"WilsonDEBennettJEBaileyJW. 1968. Serologic grouping of Cryptococcus neoformans. Proc. Soc. Exp. Biol. Med. 127:820\u2013823.","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/432486"},{"key":"e_1_3_2_7_2","first-page":"865","article-title":"Emergence of Cryptococcus gattii\u2014Pacific Northwest, 2004\u20132010","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","unstructured":"Centers for Disease Control and Prevention. 2010. Emergence of Cryptococcus gattii\u2014Pacific Northwest, 2004\u20132010. Morb. Mortal. Wkly. Rep. 59:865\u2013868.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/clinids\/23.1.91","article-title":"Individual and environmental factors associated with infection due to Cryptococcus neoformans serotype D","volume":"23","author":"Dromer F","year":"1996","unstructured":"DromerFMathoulinSDupontBLetenneurLRoninO, French Cryptococcosis Study Group. 1996. Individual and environmental factors associated with infection due to Cryptococcus neoformans serotype D. Clin. Infect. Dis. 23:91\u201396.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a113861"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1439-0507.1997.tb00235.x","article-title":"Prevalence of serotype D in Cryptococcus neoformans isolates from HIV positive and HIV negative patients in Italy","volume":"40","author":"Tortorano AM","year":"1997","unstructured":"TortoranoAMVivianiMARigoniALCogliatiMRoverselliAPaganoA. 1997. Prevalence of serotype D in Cryptococcus neoformans isolates from HIV positive and HIV negative patients in Italy. Mycoses 40:297\u2013302.","journal-title":"Mycoses"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.05052-11"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0008-6215(95)00397-5","article-title":"Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans Cap70 as determined by 2D NMR spectroscopy","volume":"283","author":"Bacon BE","year":"1996","unstructured":"BaconBECherniakRKwon-ChungKJJacobsonES. 1996. Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans Cap70 as determined by 2D NMR spectroscopy. Carbohydr. Res. 283:95\u2013110.","journal-title":"Carbohydr. Res."},{"key":"e_1_3_2_13_2","unstructured":"ReidA. 2012. Bringing the lab to the patient: developing point-of-care diagnostics for resource limited settings. American Academy of Microbiology Washington DC. http:\/\/academy.asm.org\/index.php\/colloquium-program\/browse-all-reports\/495-bringing-the-lab-to-the-patient-developing-point-of-care-diagnostics-for-resource-limited-settings-2012."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/cid\/cis725","article-title":"Reconsidering cryptococcal antigen screening in the U.S. among persons with CD4 <100 cells\/mcL","volume":"55","author":"Rajasingham R","year":"2012","unstructured":"RajasinghamRBoulwareDR. 2012. Reconsidering cryptococcal antigen screening in the U.S. among persons with CD4 <100 cells\/mcL. Clin. Infect. Dis. 55:1742\u20131744.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/1545109712459077","article-title":"Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation","volume":"11","author":"Jarvis JN","year":"2012","unstructured":"JarvisJNGovenderNChillerTParkBJLongleyNMeintjesGBekkerLGWoodRLawnSDHarrisonTS. 2012. Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation. J. Int. Assoc. Physicians AIDS Care (Chic.). 11:374\u2013379.","journal-title":"J. Int. Assoc. Physicians AIDS Care (Chic.)."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00732-12","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00732-12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:49:04Z","timestamp":1627591744000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00732-12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["10.1128\/CVI.00732-12"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00732-12","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"2012-12-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-01-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-03-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}